Clinical characteristics of the asthma-COPD overlap syndrome--a systematic review
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
Clinical characteristics of the asthma-COPD overlap syndrome--a systematic review. / Nielsen, Mia; Bårnes, Camilla Boslev; Ulrik, Charlotte Suppli.
I: International Journal of Chronic Obstructive Pulmonary Disease, Bind 10, Nr. 1, 2015, s. 1443-54.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Clinical characteristics of the asthma-COPD overlap syndrome--a systematic review
AU - Nielsen, Mia
AU - Bårnes, Camilla Boslev
AU - Ulrik, Charlotte Suppli
PY - 2015
Y1 - 2015
N2 - BACKGROUND AND OBJECTIVE: In recent years, the so-called asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) has received much attention, not least because elderly individuals may present characteristics suggesting a diagnosis of both asthma and COPD. At present, ACOS is described clinically as persistent airflow limitation combined with features of both asthma and COPD. The aim of this paper is, therefore, to review the currently available literature focusing on symptoms and clinical characteristics of patients regarded as having ACOS.METHODS: Based on the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines, a systematic literature review was performed.RESULTS: A total of 11 studies met the inclusion criteria for the present review. All studies dealing with dyspnea (self-reported or assessed by the Medical Research Council dyspnea scale) reported more dyspnea among patients classified as having ACOS compared to the COPD and asthma groups. In line with this, ACOS patients have more concomitant wheezing and seem to have more cough and sputum production. Compared to COPD-only patients, the ACOS patients were found to have lower FEV1% predicted and FEV1/FVC ratio in spite of lower mean life-time tobacco exposure. Furthermore, studies have revealed that ACOS patients seem to have not only more frequent but also more severe exacerbations. Comorbidity, not least diabetes, has also been reported in a few studies, with a higher prevalence among ACOS patients. However, it should be acknowledged that only a limited number of studies have addressed the various comorbidities in patients with ACOS.CONCLUSION: The available studies indicate that ACOS patients may have more symptoms and a higher exacerbation rate than patients with asthma and COPD only, and by that, probably a higher overall respiratory-related morbidity. Similar to patients with COPD, ACOS patients seem to have a high occurrence of comorbidity, including diabetes. Further research into the ACOS, not least from well-defined prospective studies, is clearly needed.
AB - BACKGROUND AND OBJECTIVE: In recent years, the so-called asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) has received much attention, not least because elderly individuals may present characteristics suggesting a diagnosis of both asthma and COPD. At present, ACOS is described clinically as persistent airflow limitation combined with features of both asthma and COPD. The aim of this paper is, therefore, to review the currently available literature focusing on symptoms and clinical characteristics of patients regarded as having ACOS.METHODS: Based on the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines, a systematic literature review was performed.RESULTS: A total of 11 studies met the inclusion criteria for the present review. All studies dealing with dyspnea (self-reported or assessed by the Medical Research Council dyspnea scale) reported more dyspnea among patients classified as having ACOS compared to the COPD and asthma groups. In line with this, ACOS patients have more concomitant wheezing and seem to have more cough and sputum production. Compared to COPD-only patients, the ACOS patients were found to have lower FEV1% predicted and FEV1/FVC ratio in spite of lower mean life-time tobacco exposure. Furthermore, studies have revealed that ACOS patients seem to have not only more frequent but also more severe exacerbations. Comorbidity, not least diabetes, has also been reported in a few studies, with a higher prevalence among ACOS patients. However, it should be acknowledged that only a limited number of studies have addressed the various comorbidities in patients with ACOS.CONCLUSION: The available studies indicate that ACOS patients may have more symptoms and a higher exacerbation rate than patients with asthma and COPD only, and by that, probably a higher overall respiratory-related morbidity. Similar to patients with COPD, ACOS patients seem to have a high occurrence of comorbidity, including diabetes. Further research into the ACOS, not least from well-defined prospective studies, is clearly needed.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Asthma
KW - Comorbidity
KW - Diabetes Mellitus
KW - Disease Progression
KW - Female
KW - Forced Expiratory Volume
KW - Humans
KW - Lung
KW - Male
KW - Middle Aged
KW - Prognosis
KW - Pulmonary Disease, Chronic Obstructive
KW - Risk Factors
KW - Syndrome
KW - Vital Capacity
KW - Young Adult
U2 - 10.2147/COPD.S85363
DO - 10.2147/COPD.S85363
M3 - Review
C2 - 26251584
VL - 10
SP - 1443
EP - 1454
JO - International Journal of COPD
JF - International Journal of COPD
SN - 1176-9106
IS - 1
ER -
ID: 162338040